Tanalys

Market Notice 5/23 – Information regarding the rights issue from Peptonic Medical AB

Pending decision at the Extra General Meeting January 9, 2023 the last day of trading in the company’s shares (PMED) including the right to receive unit rights is January 9, 2023. The first day excluding the right to obtain the rights is January 10, 2023.

One (1) share entitles the owner to one (1) unit right. One (1) unit right entitle the owner to subscribe for one (1) new unit, at the price of SEK 0:28.

One unit consist of four (4) new shares and one (1) free subscription option of TO2, one (1) free subscription option of TO3 and one (1) free subscription option of TO4 (4:1 á SEK 0:07). 

The subscription period lasts from January 13, 2023 to January 27, 2023.

Information about the unit right: 

Shortname:   PMED UR
ISIN-code: SE0019354655
Orderbook-ID: BVHC
CFI: RSIXXR
FISN: PEPTONICME/SUBS RTS NL PD
First day of trading: January 13, 2023
Last day of trading:  January 24, 2023
Market Segment: SPSE
MIC Code: XSAT
Tick table/liquidity band #: A (Other instruments)

Information about the paid subscribed unit:  

Shortname: PMED BTU 
ISIN-code: SE0019354663
Orderbook-ID: BVHB
CFI: MCMUXR
FISN: PEPTONICME/UT 4 AK + 3 TO
Trading period:
January 13, 2023 until the registration of the issue at Bolagsverket.
Market Segment: SPSE
MIC Code:  XSAT
Tick table/liquidity band #: A (Other instruments)

Please be advised that if the rights issue give rise to a conversion factor, all overnight orders in the company’s orderbook will be flushed. If so this will occur after closing on January 9, 2023.

Stockholm January 4, 2023

Spotlight Stock Market
08-51168000 
backoffice@spotlightstockmarket.com

Exit mobile version